| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLA2G4B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | IL11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CT45A6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MRPS15 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PRL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ZBED6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OTP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RP11-294C11.3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MAGEA10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | FRMD4B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
